{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:07:39Z","timestamp":1793934459037,"version":"4.8.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Sanming Project of Medicine in Shenzen Municipality,China","award":["20212001132"],"award-info":[{"award-number":["20212001132"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["72091514"],"award-info":[{"award-number":["72091514"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-026-14364-x","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T09:36:15Z","timestamp":1774517775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Direct economic burden of 0.9\u00a0million hospitalized cancer patients in Shenzhen, China, 2016\u20132022"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4864-1195","authenticated-orcid":false,"given":"Hanbo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peicheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huatang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wannian","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3545-1525","authenticated-orcid":false,"given":"Jiming","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"issue":"11","key":"14364_CR1","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1007\/s11427-022-2240-6","volume":"66","author":"Y Wang","year":"2023","unstructured":"Wang Y, Yan Q, Fan C, et al. Overview and countermeasures of cancer burden in China. Sci China Life Sci. 2023 Nov;66(11):2515\u201326. https:\/\/doi.org\/10.1007\/s11427-022-2240-6.","journal-title":"Science China-Life Sciences Nov"},{"key":"14364_CR2","doi-asserted-by":"publisher","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A, Cancer statistics, 2022. CA Cancer J Clin. 2022 Jan;72(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21708.","DOI":"10.3322\/caac.21708"},{"issue":"5","key":"14364_CR3","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/eurpub\/ckz216","volume":"30","author":"C Mattiuzzi","year":"2020","unstructured":"Mattiuzzi C, Lippi G. Cancer statistics: a comparison between World Health Organization (WHO) and Global Burden of Disease (GBD). European J Public Health. 2020 Oct;30(5):1026\u20137. https:\/\/doi.org\/10.1093\/eurpub\/ckz216.","journal-title":"European J Public Health Oct"},{"key":"14364_CR4","doi-asserted-by":"publisher","unstructured":"Islami F, Ward EM, Sung H, et al. Annual report to the nation on the status of cancer, part 1: national cancer statistics. J Natl Cancer Inst. 2021 Dec;113(12):1648\u20131669. https:\/\/doi.org\/10.1093\/jnci\/djab131.","DOI":"10.1093\/jnci\/djab131"},{"issue":"10","key":"14364_CR5","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/cac2.12197","volume":"41","author":"H Qiu","year":"2021","unstructured":"Qiu H, Cao S, Xu R. Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020. Cancer Commun. 2021 Oct;41(10):1037\u201348. https:\/\/doi.org\/10.1002\/cac2.12197.","journal-title":"Cancer Communications Oct"},{"issue":"7","key":"14364_CR6","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/cm9.0000000000001474","volume":"134","author":"W Cao","year":"2021","unstructured":"Cao W, Chen HD, Yu YW, Li N, Chen WQ. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chinese Med J. 2021 Apr;134(7):783\u201391. https:\/\/doi.org\/10.1097\/cm9.0000000000001474.","journal-title":"Chinese Med Journal Apr"},{"issue":"5","key":"14364_CR7","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/cm9.0000000000002108","volume":"135","author":"CF Xia","year":"2022","unstructured":"Xia CF, Dong XS, Li H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chinese Med J. 2022 Mar;135(5):584\u201390. https:\/\/doi.org\/10.1097\/cm9.0000000000002108.","journal-title":"Chinese Med Journal Mar"},{"key":"14364_CR8","doi-asserted-by":"publisher","unstructured":"Feng RM, Zong YN, Cao SM, Xu RH. Apr. Current cancer situation in China: Good or bad news from the 2018 global cancer statistics? Cancer Commun. 2019;3922. https:\/\/doi.org\/10.1186\/s40880-019-0368-6.","DOI":"10.1186\/s40880-019-0368-6"},{"key":"14364_CR9","doi-asserted-by":"crossref","unstructured":"Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. Cancer J Clin. 2016;(2):66.","DOI":"10.3322\/caac.21338"},{"key":"14364_CR10","doi-asserted-by":"publisher","unstructured":"Qi J, Li M, Wang L et al. National and subnational trends in cancer burden in China, 2005-20: an analysis of national mortality surveillance data. Lancet Public Health. 2023;8(12):e943-e955. https:\/\/doi.org\/10.1016\/s2468-26672300211-6.","DOI":"10.1016\/s2468-26672300211-6"},{"issue":"2","key":"14364_CR11","doi-asserted-by":"publisher","first-page":"e2255388","DOI":"10.1001\/jamanetworkopen.2022.55388","volume":"6","author":"AN Ehsan","year":"2023","unstructured":"Ehsan AN, Wu CA, Minasian A, et al. Financial toxicity among patients with breast cancer worldwide: a systematic review and meta-analysis. Jama Netw Open. 2023 Feb;6(2):e2255388. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.55388.","journal-title":"Jama Netw Open Feb"},{"issue":"6","key":"14364_CR12","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1001\/jamaoto.2022.0660","volume":"148","author":"N Uppal","year":"2022","unstructured":"Uppal N, Cunningham C, James B. The cost and financial burden of thyroid cancer on patients in the USA review and directions for future research. JAMA Otolaryngol Head Neck Surg. 2022 Jun;148(6):568\u201375. https:\/\/doi.org\/10.1001\/jamaoto.2022.0660.","journal-title":"Jama Otolaryngology-Head &amp; Neck Surgery Jun"},{"key":"14364_CR13","doi-asserted-by":"publisher","unstructured":"Ryerson AB, Eheman CR, Altekruse SF, et al. Annual report to the nation on the status of cancer, 1975\u20132012, featuring the increasing incidence of liver cancer. Cancer. 2016 May;122(9):1312\u20131337. https:\/\/doi.org\/10.1002\/cncr.29936.","DOI":"10.1002\/cncr.29936"},{"issue":"1","key":"14364_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/ijerph18010012","volume":"18","author":"BT Tran","year":"2021","unstructured":"Tran BT, Choi KS, Nguyen TX, et al. The direct and indirect costs of colorectal cancer in Vietnam: an economic analysis from a social perspective. Int J Environ Res Public Health. 2021 Jan;18(1):12. https:\/\/doi.org\/10.3390\/ijerph18010012.","journal-title":"International J Environ Res Public Health Jan"},{"issue":"11","key":"14364_CR15","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1002\/cncr.33559","volume":"127","author":"JM Salsman","year":"2021","unstructured":"Salsman JM, Danhauer SC, Moore JB, et al. Systematic review of financial burden assessment in cancer: Evaluation of measures and utility among adolescents and young adults and caregivers. Cancer. 2021 Jun;127(11):1739\u201348. https:\/\/doi.org\/10.1002\/cncr.33559.","journal-title":"Cancer Jun"},{"issue":"1","key":"14364_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/1759-7714.13616","volume":"12","author":"A Buja","year":"2021","unstructured":"Buja A, Rivera M, De Polo A, et al. Estimated direct costs of non-small cell lung cancer by stage at diagnosis and disease management phase: a whole-disease model. Thoracic Cancer. 2021 Jan;12(1):13\u201320. https:\/\/doi.org\/10.1111\/1759-7714.13616.","journal-title":"Thoracic Cancer Jan"},{"issue":"2","key":"14364_CR17","doi-asserted-by":"publisher","first-page":"E342","DOI":"10.1002\/onco.13604","volume":"26","author":"H Moraliyage","year":"2021","unstructured":"Moraliyage H, De Silva D, Ranasinghe W, et al. Cancer in lockdown: impact of the COVID-19 pandemic on patients with cancer. Oncologist. 2021 Feb;26(2):E342\u20134. https:\/\/doi.org\/10.1002\/onco.13604.","journal-title":"Oncologist Feb"},{"key":"14364_CR18","unstructured":"Municipality Health Commission of Shenzhen. Early screening and treatment for cancer project was officially launched in Shenzhen. 2018. http:\/\/wjw.sz.gov.cn\/gzdt\/content\/post_3208524.html"},{"key":"14364_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.canlet.2021.02.017","volume":"506","author":"MM Cao","year":"2021","unstructured":"Cao MM, Li H, Sun DQ, et al. Cancer screening in China: The current status, challenges, and suggestions. Cancer Lett. 2021 May;506:120\u20137. https:\/\/doi.org\/10.1016\/j.canlet.2021.02.017.","journal-title":"Cancer Letters May"},{"key":"14364_CR20","doi-asserted-by":"publisher","unstructured":"Krist AH, Davidson KW, Mangione CM, et al. Screening for lung cancer: US Preventive Services Task Force recommendation statement. J Am Med Assoc. 2021 Mar;325(10):962\u201370. https:\/\/doi.org\/10.1001\/jama.2021.1117.","DOI":"10.1001\/jama.2021.1117"},{"issue":"8","key":"14364_CR21","doi-asserted-by":"publisher","first-page":"e2121403","DOI":"10.1001\/jamanetworkopen.2021.21403","volume":"4","author":"RY Xia","year":"2021","unstructured":"Xia RY, Zeng HM, Liu WJ, et al. Estimated cost-effectiveness of endoscopic screening for upper gastrointestinal tract cancer in high-risk areas in China. JAMA Netw Open. 2021 Aug;4(8):e2121403. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.21403.","journal-title":"Jama Netw Open Aug"},{"key":"14364_CR22","doi-asserted-by":"publisher","unstructured":"Mao WH, Tang SL, Zhu Y, Xie ZN, Chen W. Financial burden of healthcare for cancer patients with social medical insurance: a multi-centered study in urban China. Int J Equity Health. 2017 Oct;16180. https:\/\/doi.org\/10.1186\/s12939-017-0675-y.","DOI":"10.1186\/s12939-017-0675-y"},{"issue":"3","key":"14364_CR23","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/hpm.2951","volume":"35","author":"XY Liu","year":"2020","unstructured":"Liu XY, Zhang QL, Xu Y, Wu XY, Wang XF. Trend analysis of medical expenses in Shenzhen after China\u2019s new health-care reforms. International J Health Plann Manag. 2020 May;35(3):760\u201372. https:\/\/doi.org\/10.1002\/hpm.2951.","journal-title":"International J Health Plann Management May"},{"key":"14364_CR24","unstructured":"Shenzhen Municipal Bureau of Human Resources and Social Security. Notice of Shenzhen Municipal Bureau of Human Resources and Social Security on Issuing the Trial Measures for Supplementary Medical Insurance for Major Diseases in Shenzhen. 2019. http:\/\/hsa.sz.gov.cn\/zwgk\/zcfgjzcjd\/zcfg\/ylbx\/content\/post_1932384.html"},{"issue":"4","key":"14364_CR25","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/hpm.1109","volume":"26","author":"SL Barber","year":"2011","unstructured":"Barber SL, Yao L. Development and status of health insurance systems in China. Int J Health Plann Manag. 2011 Oct-Dec;26(4):339\u201356. https:\/\/doi.org\/10.1002\/hpm.1109.","journal-title":"International J Health Plann Management Oct-Dec"},{"key":"14364_CR26","doi-asserted-by":"publisher","unstructured":"Yang Y, Zhang YC, Wagner AK, Li HQY, Shi LW, Guan XD. The impact of government reimbursement negotiation on targeted anticancer medicines use and cost in China: a cohort study based on national health insurance data. J Glob Health. 2023;2023:1304083. https:\/\/doi.org\/10.7189\/jogh.13.04083.","DOI":"10.7189\/jogh.13.04083"},{"issue":"7","key":"14364_CR27","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00520-024-08693-y","volume":"32","author":"Y Wang","year":"2024","unstructured":"Wang Y, Luo BY, Wang XD, Ji QM, Cao X. Financial toxicity, coping strategies, and quality of life among Chinese patients with hematologic malignancies: a cross-sectional study. Supportive Care Cancer. 2024 Jul;32(7):475. https:\/\/doi.org\/10.1007\/s00520-024-08693-y.","journal-title":"Supportive Care Cancer Jul"},{"issue":"5","key":"14364_CR28","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1002\/ijc.33298","volume":"148","author":"YH Liu","year":"2021","unstructured":"Liu YH, Lai FH, Long JY, et al. Screening and the epidemic of thyroid cancer in China: an analysis of national representative inpatient and commercial insurance databases. International J Cancer. 2021 Mar;148(5):1106\u201314. https:\/\/doi.org\/10.1002\/ijc.33298.","journal-title":"International J Cancer Mar"},{"issue":"2","key":"14364_CR29","doi-asserted-by":"publisher","first-page":"020702","DOI":"10.7189\/jogh.09.020702","volume":"9","author":"YF Diao","year":"2019","unstructured":"Diao YF, Qian J, Liu Y, et al. How government insurance coverage changed the utilization and affordability of expensive targeted anti-cancer medicines in China: an interrupted time-series study. J Glob Health. 2019 Dec;9(2):020702. https:\/\/doi.org\/10.7189\/jogh.09.020702.","journal-title":"Journal Global Health Dec"},{"issue":"1","key":"14364_CR30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/ijc.33183","volume":"148","author":"YX Xie","year":"2021","unstructured":"Xie YX, Valdimarsd\u00f3ttir UA, Wang CS, et al. Public health insurance and cancer-specific mortality risk among patients with breast cancer: a prospective cohort study in China. Int J Cancer. 2021 Jan;148(1):28\u201337. https:\/\/doi.org\/10.1002\/ijc.33183.","journal-title":"International J Cancer Jan"},{"issue":"1","key":"14364_CR31","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1186\/s12905-022-02104-2","volume":"22","author":"XT Han","year":"2022","unstructured":"Han XT, Wang ZH, Huang DM, et al. Analysis of the disease burden trend of malignant tumors of the female reproductive system in China from 2006 to 2020. BMC Womens Health. 2022 Dec;22(1):504. https:\/\/doi.org\/10.1186\/s12905-022-02104-2.","journal-title":"Bmc Womens Health Dec"},{"key":"14364_CR32","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1186\/s40880-015-0013-y","volume":"14","author":"H-B Zhou","year":"2015","unstructured":"Zhou H-B, Liu S-Y, Lei L, et al. Spatio-temporal analysis of female breast cancer incidence in Shenzhen, 2007\u20132012. Chin J Cancer. 2015 May;14:3413. https:\/\/doi.org\/10.1186\/s40880-015-0013-y.","journal-title":"Chin J Cancer"},{"issue":"6","key":"14364_CR33","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.cgh.2009.01.008","volume":"7","author":"SP Nguyen","year":"2009","unstructured":"Nguyen SP, Bent S, Chen YH, Terdiman JP. Gender as a risk factor for advanced neoplasia and colorectal cancer: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2009 Jun;7(6):676\u201381. https:\/\/doi.org\/10.1016\/j.cgh.2009.01.008.","journal-title":"Clinical Gastroenterol Hepatology Jun"},{"issue":"11","key":"14364_CR34","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1158\/1055-9965.Epi-14-0487","volume":"23","author":"CA Thompson","year":"2014","unstructured":"Thompson CA, Gomez SL, Chan A, et al. Patient and provider characteristics associated with colorectal, breast, and cervical cancer screening among Asian Americans. Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2208\u201317. https:\/\/doi.org\/10.1158\/1055-9965.Epi-14-0487.","journal-title":"Cancer Epidemiol Biomarkers &amp; Prevention Nov"},{"key":"14364_CR35","doi-asserted-by":"publisher","unstructured":"Zhou H, Wu Z, Wang H, et al. Analysis of the spectrum and characteristics of pediatric cancer based on hospital information systems in China. Cancer Manag Res. 2021;13:1205\u20131214. https:\/\/doi.org\/10.2147\/cmar.S279427.","DOI":"10.2147\/cmar.S279427"},{"issue":"3","key":"14364_CR36","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/ped4.12213","volume":"4","author":"M Jin","year":"2020","unstructured":"Jin M, Tian Z, Xie Y, et al. Diagnosis and treatment of infantile malignant solid tumors in Beijing, China: a multicenter 10-year retrospective study. Pediatric Investigation. 2020 Sep;4(3):178\u201385. https:\/\/doi.org\/10.1002\/ped4.12213.","journal-title":"Pediatric Investigation Sep"},{"issue":"3","key":"14364_CR37","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.gaceta.2020.12.035","volume":"36","author":"O Ibarrondo","year":"2022","unstructured":"Ibarrondo O, Lizeaga G, Miguel Martinez-Llorente J, Larranaga I, Soto-Gordoa M, Alvarez-Lopez I. Health care costs of breast, prostate, colorectal and lung cancer care by clinical stage and cost component. Gaceta Sanitaria. 2022 May-Jun;36(3):246\u201352. https:\/\/doi.org\/10.1016\/j.gaceta.2020.12.035.","journal-title":"Gaceta Sanitaria May-Jun"},{"issue":"6","key":"14364_CR38","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3322\/caac.21637","volume":"70","author":"KD Miller","year":"2020","unstructured":"Miller KD, Fidler-Benaoudia M, Keegan TH, Hipp HS, Jemal A, Siegel RL. Cancer statistics for adolescents and young adults, 2020. CA Cancer J Clin. 2020 Nov;70(6):443\u201359. https:\/\/doi.org\/10.3322\/caac.21637.","journal-title":"Ca-a Cancer J Clinicians Nov"},{"issue":"10","key":"14364_CR39","doi-asserted-by":"publisher","first-page":"10383","DOI":"10.21037\/apm-21-2075","volume":"10","author":"WH Mao","year":"2021","unstructured":"Mao WH, Feng XR, Wang YM, Zeng BJ, Zhang YH, Luo KF. Country-based demographics, patterns of treatment seeking, and disease burden for malignant tumor patients in China. Ann Palliat Med. 2021 Oct;10(10):10383\u201390. https:\/\/doi.org\/10.21037\/apm-21-2075.","journal-title":"Annals Palliat Medicine Oct"},{"issue":"15","key":"14364_CR40","doi-asserted-by":"publisher","first-page":"312","DOI":"10.46234\/ccdcw2022.037","volume":"4","author":"XJ Long","year":"2022","unstructured":"Long XJ, Lu FF, Xiang XL, et al. Economic burden of malignant tumors - Yichang City, Hubei Province, China, 2019. China CDC Weekly. 2022 Apr;4(15):312\u20136. https:\/\/doi.org\/10.46234\/ccdcw2022.037.","journal-title":"China Cdc Weekly Apr"},{"issue":"6","key":"14364_CR41","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1002\/cam4.2184","volume":"8","author":"XJ Yin","year":"2019","unstructured":"Yin XJ, Xu Y, Man XW, et al. Direct costs of both inpatient and outpatient care for all type cancers: the evidence from Beijing, China. Cancer Med. 2019 Jun;8(6):3250\u201360. https:\/\/doi.org\/10.1002\/cam4.2184.","journal-title":"Cancer Med Jun"},{"issue":"5","key":"14364_CR42","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1158\/1940-6207.Capr-19-0527","volume":"13","author":"A Piscitello","year":"2020","unstructured":"Piscitello A, Edwards DKV. Estimating the screening-eligible population size, ages 45\u201374, at average risk to develop colorectal cancer in the United States. Cancer Prev Res. 2020 May;13(5):443\u20137. https:\/\/doi.org\/10.1158\/1940-6207.Capr-19-0527.","journal-title":"Cancer Prev Research May"},{"key":"14364_CR43","doi-asserted-by":"publisher","unstructured":"Jafari A, Alamdarloo PM, Dehghani M, Bastani P, Ravangard R. Economic burden of colorectal cancer: a case of Fars, Iran. Cancer Control. 2021 Jan;2810732748211009952. https:\/\/doi.org\/10.1177\/10732748211009952.","DOI":"10.1177\/10732748211009952"},{"issue":"11","key":"14364_CR44","doi-asserted-by":"publisher","first-page":"101822","DOI":"10.1016\/j.jsps.2023.101822","volume":"31","author":"B Balkhi","year":"2023","unstructured":"Balkhi B, Alghamdi A, Alqahtani S, Al Najjar M, Al Harbi A, Bin Traiki T. Colorectal cancer-related resource utilization and healthcare costs in Saudi Arabia. Saudi Pharm J. 2023 Nov;31(11):101822. https:\/\/doi.org\/10.1016\/j.jsps.2023.101822.","journal-title":"Saudi Pharm Journal Nov"},{"issue":"4","key":"14364_CR45","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1001\/jamaoncol.2022.7826","volume":"9","author":"SM Chen","year":"2023","unstructured":"Chen SM, Cao Z, Prettner K, et al. Estimates and projections of the global economic cost of 29 cancers in 204 countries and territories From 2020 to 2050. JAMA Oncol. 2023 Apr;9(4):465\u201372. https:\/\/doi.org\/10.1001\/jamaoncol.2022.7826.","journal-title":"Jama Oncology Apr"},{"key":"14364_CR46","doi-asserted-by":"publisher","unstructured":"Huang S-Y, Chen H-M, Liao K-H, Ko B-S, Hsiao F-Y. Economic burden of cancers in Taiwan: a direct and indirect cost estimate for 2007\u20132017. BMJ Open. 2020;10(10)e036341. https:\/\/doi.org\/10.1136\/bmjopen-2019-036341.","DOI":"10.1136\/bmjopen-2019-036341"},{"issue":"3","key":"14364_CR47","doi-asserted-by":"publisher","first-page":"101027","DOI":"10.1016\/j.hlpt.2025.101027","volume":"14","author":"K Matsumoto","year":"2025","unstructured":"Matsumoto K, Seto K, Hatakeyama Y, et al. The impact of the cancer control equity policy for cancer care on social burdens. Health Policy Technol. 2025;14(3):101027.","journal-title":"Health Policy Technol"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-026-14364-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-14364-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-14364-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:10:30Z","timestamp":1777947030000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12913-026-14364-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["14364"],"URL":"https:\/\/doi.org\/10.1186\/s12913-026-14364-x","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"3 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Tsinghua University (NO. THU01-20240009). This study used anonymous, secondary data from the Health Commission of Shenzhen Municipality and Shenzhen Health Development Research and Data Management Center. The Tsinghua University Science and Technology Ethics Committee (Medicine) does not require informed consent for research that only uses anonymous, de-identified registry-based secondary data. According to the regulations and the nature of our data source, Informed Consent was waived by ethic committee of Tsinghua University Science and Technology Ethics Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"636"}}